HAMP and metabolic dysfunction-associated steatotic liver disease: To evaluate the possible effect of inflammatory activation on hepcidin levels in patients with dysmetabolic alterations, we measured IL-6 concentrations in DIOS and C-NAFLD compared to C-Donors.